Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

177 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Alteration of hormone levels in normal males given the anabolic steroid stanozolol.
Small M, Beastall GH, Semple CG, Cowan RA, Forbes CD. Small M, et al. Clin Endocrinol (Oxf). 1984 Jul;21(1):49-55. doi: 10.1111/j.1365-2265.1984.tb00135.x. Clin Endocrinol (Oxf). 1984. PMID: 6430603
Hormone binding globulins and anticonvulsant therapy.
Beastall GH, Cowan RA, Gray JM, Fogelman I. Beastall GH, et al. Scott Med J. 1985 Apr;30(2):101-5. doi: 10.1177/003693308503000206. Scott Med J. 1985. PMID: 3925547
Calcium antagonists and endocrine status: lack of effect of oral verapamil on pituitary-testicular and pituitary-thyroid function.
Semple CG, Thomson JA, Beastall GH, Lorimer AR. Semple CG, et al. Br J Clin Pharmacol. 1984 Feb;17(2):179-82. doi: 10.1111/j.1365-2125.1984.tb02336.x. Br J Clin Pharmacol. 1984. PMID: 6422973 Free PMC article.
The effect of low-dose dopamine infusion on anterior pituitary hormone secretion in normal female subjects.
Connell JM, Ball SG, Inglis GC, Beastall GH, Davies DL. Connell JM, et al. Clin Sci (Lond). 1984 Aug;67(2):219-23. doi: 10.1042/cs0670219. Clin Sci (Lond). 1984. PMID: 6744790 Clinical Trial.
No change in thyrotrophin (TSH), growth hormone (GH) or luteinizing hormone (LH) was seen during either rate of dopamine infusion compared with control. While dopamine infusion at 0.1 micrograms min-1 kg-1 caused significant inhibition of prolactin secretion in normal fema …
No change in thyrotrophin (TSH), growth hormone (GH) or luteinizing hormone (LH) was seen during either rate of dopamine infusion com …
Effects of treatment with oestradiol/levonorgestrel on bone, lipoproteins and hormone status in postmenopausal women.
Farish E, Hart DM, Gray CE, Beastall G, Fletcher CD, Lindsay R. Farish E, et al. Clin Endocrinol (Oxf). 1989 Nov;31(5):607-15. doi: 10.1111/j.1365-2265.1989.tb01285.x. Clin Endocrinol (Oxf). 1989. PMID: 2516789
Trilostane and the normal hypothalamic-pituitary-adrenocortical axis.
Semple CG, Thomson JA, Stark AN, McDonald M, Beastall GH. Semple CG, et al. Clin Endocrinol (Oxf). 1982 Dec;17(6):569-75. doi: 10.1111/j.1365-2265.1982.tb01629.x. Clin Endocrinol (Oxf). 1982. PMID: 6299624
The effect of oestrogen (mestranol) on the thyrotrophin response to thyrotrophin releasing hormone in postmenopausal oophorectomised women.
Abdalla HI, Beastall GH, Hart DM. Abdalla HI, et al. Clin Endocrinol (Oxf). 1984 Jul;21(1):65-9. doi: 10.1111/j.1365-2265.1984.tb00137.x. Clin Endocrinol (Oxf). 1984. PMID: 6430605 Clinical Trial.
Metoclopramide stimulation: a test of growth hormone reserve in adolescent males.
Cohen HN, Hay ID, Thomson JA, Logue F, Ratcliffe WA, Beastall GH. Cohen HN, et al. Clin Endocrinol (Oxf). 1979 Jul;11(1):89-93. doi: 10.1111/j.1365-2265.1979.tb03050.x. Clin Endocrinol (Oxf). 1979. PMID: 117953 Clinical Trial.
A comparison was made between the growth hormone (GH) response to metoclopramide ('Maxolon'--Beecham Laboratories) and insulin induced hypoglycaemia in thirty-five short adolescent males. Both tests initially caused adequate release of GH from the pituitary gland in …
A comparison was made between the growth hormone (GH) response to metoclopramide ('Maxolon'--Beecham Laboratories) and insulin induce …
177 results
Jump to page
Feedback